5α-reductase inhibitors and the risk of grade reclassification for men with long-term follow-up on active surveillance for prostate cancer.

被引：0
|
作者：
Finelli, Antonio
Timilshina, Narhari
Komisarenko, Maria
Sowerby, Robert
Hamilton, Robert James
Zlotta, Alexandre
Fleshner, Neil Eric
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Toronto, Brampton, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Re: Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort with Localized Prostate Cancer
    Ploussar, Guillaume
    Mongiat-Artus, Pierre
    EUROPEAN UROLOGY, 2010, 58 (01) : 179 - 180
  • [22] Re: Long-Term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 194 (05): : 1286 - 1286
  • [23] When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer.
    Cooperberg, Matthew R.
    Faino, Anna V.
    Newcomb, Lisa F.
    Carroll, Peter
    Kearns, James T.
    Brooks, James D.
    Fabrizio, Michael
    Gleave, Martin
    Morgan, Todd Matthew
    Dash, Atreya
    Nelson, Peter
    Thompson, Ian Murchie
    Wagner, Andrew
    Lin, Daniel W.
    Zheng, Yingye
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [24] The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Reply
    Carroll, Peter R.
    Maggi, Martina
    JOURNAL OF UROLOGY, 2021, 206 (01): : 174 - 174
  • [25] Predictors of HRQOL duirng long-term follow-up of men treated for prostate cancer
    Huang, George J.
    Sadetsky, Natalia
    Carroll, Peter R.
    Person, David F.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 3 - 4
  • [26] OUTCOMES AND IMPLICATIONS OF FOLLOW-UP BIOPSIES OF MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Smith, Angela
    Coward, Matthew
    Doak, Hoyt
    Kurpad, Raj
    Nix, Jeff
    Nielsen, Matthew
    Schultz, Heather
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 608 - 608
  • [27] Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (06): : 2233 - 2234
  • [28] Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring
    Swanson, Gregory P.
    Chen, Wencong
    Trevathan, Sean
    Hermans, Michael
    PROSTATE CANCER, 2020, 2020
  • [29] LONG-TERM RECLASSIFICATION DURING ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER: NUMBER OF REPEATED BIOPSIES EFFECT
    Nicolai, Nicola
    Marenghi, Cristina
    Badenchini, Fabio
    Magnani, Tiziana
    Villa, Sergio
    Catanzaro, Mario Achille
    Avuzzi, Barbara
    Macchi, Alberto
    Morlino, Sara
    Stagni, Silvia
    Chiorda, Barbara Noris
    Tesone, Antonio
    Torelli, Tullio
    Colecchia, Maurizio
    Casale, Alessandra
    Messina, Antonella
    Bellardita, Lara
    Zollo, Fabiana
    De Luca, Letizia
    Dordoni, Paola
    Salvioni, Roberto
    Valdagni, Riccardo
    ANTICANCER RESEARCH, 2019, 39 (03) : 1614 - 1615
  • [30] 5a-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.
    Preston, Mark A.
    Wilson, Kathryn M.
    Markt, Sarah C.
    Ge, Rongbin
    Morash, Christopher
    Stampfer, Meir J.
    Loda, Massimo
    Giovannucci, Edward
    Mucci, Lorelei A.
    Olumi, Aria F.
    JAMA INTERNAL MEDICINE, 2014, 174 (08) : 1301 - 1307
12345